CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net income (loss)	$ (100,058)	$ 103,537
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation, depletion, amortization and accretion expense	532,390	359,291
Amortization of deferred financing costs and original issue discount	5,084	7,629
Equity-based compensation expense	5,544	8,687
Price risk management activities (income) expense	84,760	(85,134)
Net cash received (paid) on settled derivative instruments	(21,012)	(4,161)
Equity method investment (income) expense	8,510	(5,431)
Loss (gain) on extinguishment of debt	60,256	0
Settlement of asset retirement obligations	(50,128)	(47,683)
Loss (gain) on sale of assets	(2,500)	0
Loss (gain) on sale of business	(86,940)	0
Changes in operating assets and liabilities:
Accounts receivable	3,076	35,127
Other current assets	(5,150)	(23,790)
Accounts payable	(43,608)	(3,890)
Other current liabilities	17,748	(22,975)
Other non-current assets and liabilities, net	(22,182)	(44,124)
Net cash provided by (used in) operating activities	385,790	277,083
Cash flows from investing activities:
Exploration, development and other capital expenditures	(269,170)	(298,658)
Cash acquired in excess of payments for acquisitions	0	17,617
Payments for acquisitions, net of cash acquired	(916,045)	0
Proceeds from (cash paid for) sale of property and equipment, net	0	(8,488)
Contributions to equity method investees	(19,627)	(15,260)
Investment in intangible assets	0	(7,796)
Proceeds from sales of businesses	141,997	0
Net cash provided by (used in) investing activities	(1,062,845)	(312,585)
Cash flows from financing activities:
Issuance of common stock	387,717	0
Issuance of senior notes	1,250,000	0
Redemption of senior notes	(897,116)	(15,000)
Proceeds from Bank Credit Facility	770,000	505,000
Repayment of Bank Credit Facility	(745,000)	(305,000)
Deferred financing costs	(27,386)	(11,775)
Other deferred payments	(1,234)	(462)
Payments of finance lease	(8,747)	(8,026)
Purchase of treasury stock	(39,326)	(47,504)
Employee stock awards tax withholdings	(5,687)	(7,378)
Net cash provided by (used in) financing activities	683,221	109,855
Net increase (decrease) in cash, cash equivalents and restricted cash	6,166	74,353
Cash, cash equivalents and restricted cash:
Balance, beginning of period	135,999	44,145
Balance, end of period	142,165	118,498
Supplemental non-cash transactions:
Capital expenditures included in accounts payable and accrued liabilities	79,832	113,319
Supplemental cash flow information:
Interest paid, net of amounts capitalized	$ 64,452	$ 63,492